首页> 外文期刊>The Open Cardiovascular Medicine Journal >Allogeneic Blood Product Usage in Coronary Artery Bypass Grafting (CABG) with minimalized Extracorporeal Circulation System (MECC) Versus Standard On-Pump Coronary Artery Bypass Grafting
【24h】

Allogeneic Blood Product Usage in Coronary Artery Bypass Grafting (CABG) with minimalized Extracorporeal Circulation System (MECC) Versus Standard On-Pump Coronary Artery Bypass Grafting

机译:具有最小化体外循环系统(MECC)的冠状动脉旁路移植术(CABG)与标准泵上冠状动脉旁路移植术的异体血液产品使用

获取原文
       

摘要

Aim:Intraoperative allogeneic blood product transfusion (ABPT) in cardiac surgery is associated with worse overall outcome, including mortality. The objective of this study was to evaluate the ABPTs in minimalized extracorporeal cardiopulmonary (M
机译:目的:心脏手术中术中异体血制品输注(ABPT)与包括死亡在内的总体预后差有关。这项研究的目的是评估最小化体外心肺(M

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号